Additionally, the results showing that AMG386 reduces p‐ERK1/2 and activates STAT3 in tumor endothelial cells are consistent with the reduced activity of EphrinB in tumor endothelial cells of mice treated with AMG386 (Fig 6C). Here, STAT3 is linked to neoplasm.